X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (415) 415
humans (399) 399
male (373) 373
quinolizines - therapeutic use (316) 316
index medicus (309) 309
quinolizines - pharmacology (306) 306
pharmacology & pharmacy (258) 258
alkaloids - pharmacology (254) 254
female (227) 227
rats (198) 198
alkaloids - therapeutic use (181) 181
mice (158) 158
quinolizines - administration & dosage (127) 127
adult (123) 123
dose-response relationship, drug (114) 114
matrine (114) 114
middle aged (109) 109
indoles - therapeutic use (92) 92
oxymatrine (92) 92
apoptosis (90) 90
antiemetics - therapeutic use (86) 86
quinolizines - chemistry (86) 86
rats, sprague-dawley (85) 85
quinolizines (81) 81
quinolizines - adverse effects (74) 74
alkaloids - chemistry (69) 69
oncology (68) 68
chemistry, medicinal (66) 66
expression (64) 64
neurosciences (64) 64
analysis (59) 59
apoptosis - drug effects (59) 59
aged (58) 58
cell proliferation - drug effects (58) 58
treatment outcome (56) 56
double-blind method (55) 55
quinolizines - pharmacokinetics (55) 55
adolescent (50) 50
alkaloids - administration & dosage (50) 50
cell line, tumor (48) 48
indoles - administration & dosage (48) 48
signal transduction - drug effects (48) 48
vomiting - prevention & control (47) 47
in-vitro (46) 46
biochemistry & molecular biology (45) 45
cancer (45) 45
indoles - adverse effects (45) 45
vomiting - chemically induced (45) 45
disease models, animal (44) 44
alkaloids (43) 43
azocines - pharmacology (43) 43
nicotinic agonists - pharmacology (43) 43
administration, oral (42) 42
research (42) 42
sophora - chemistry (42) 42
antiemetics - administration & dosage (41) 41
ondansetron (41) 41
rats, wistar (41) 41
nicotine (40) 40
receptors, nicotinic - metabolism (40) 40
activation (39) 39
chemotherapy (39) 39
azocines (38) 38
double-blind (38) 38
health aspects (38) 38
antiemetics - adverse effects (37) 37
fluoroquinolones (37) 37
varenicline (37) 37
cytisine (35) 35
nausea - prevention & control (35) 35
prevention (35) 35
serotonin antagonists - therapeutic use (35) 35
care and treatment (34) 34
efficacy (33) 33
nausea - chemically induced (33) 33
nicotine - pharmacology (33) 33
ondansetron - therapeutic use (33) 33
time factors (33) 33
injections, intravenous (32) 32
mice, inbred c57bl (32) 32
quinolizines - metabolism (32) 32
alkaloids - metabolism (31) 31
molecular structure (31) 31
proliferation (31) 31
dolasetron (30) 30
neoplasms - drug therapy (30) 30
phytotherapy (30) 30
proteins (30) 30
antineoplastic agents - adverse effects (29) 29
inhibition (29) 29
oxidative stress (29) 29
pharmacokinetics (29) 29
receptors, nicotinic - drug effects (29) 29
antineoplastic agents - pharmacology (28) 28
smoking cessation - methods (28) 28
acetylcholine-receptors (27) 27
anesthesiology (27) 27
biomedicine (27) 27
brain (27) 27
quinolizines - chemical synthesis (27) 27
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (693) 693
Chinese (45) 45
German (15) 15
Japanese (11) 11
Italian (8) 8
Russian (4) 4
Polish (3) 3
Spanish (3) 3
French (1) 1
Hungarian (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cochrane Database of Systematic Reviews, ISSN 1469-493X, 05/2016, Volume 2016, Issue 5, p. CD006103
Background Nicotine receptor partial agonists may help people to stop smoking by a combination of maintaining moderate levels of dopamine to counteract... 
Smoking [drug therapy] | Varenicline | Humans | RANDOMIZED CONTROLLED-TRIAL | Quinolizines [therapeutic use] | PSYCHIATRIC ADVERSE EVENTS | TOBACCO-DEPENDENCE TREATMENT | Quinoxalines [therapeutic use] | MEDICINE, GENERAL & INTERNAL | Bupropion [therapeutic use] | Nicotine [adverse effects; antagonists & inhibitors] | REPLACEMENT THERAPY | SUSTAINED-RELEASE BUPROPION | Smoking Cessation [methods] | Counseling [methods] | VARENICLINE TREATMENT | METHADONE-MAINTAINED SMOKERS | Randomized Controlled Trials as Topic | Azepines [therapeutic use] | DOUBLE-BLIND PLACEBO | Alkaloids [therapeutic use] | Nicotinic Agonists [adverse effects; therapeutic use] | Azocines [therapeutic use] | LONG-TERM SAFETY | Benzazepines [therapeutic use] | PLACEBO-CONTROLLED TRIAL | Substance Withdrawal Syndrome [prevention & control] | Heterocyclic Compounds with 4 or More Rings [therapeutic use] | Quinolizines - therapeutic use | Azepines - adverse effects | Azocines - therapeutic use | Azocines - adverse effects | Substance Withdrawal Syndrome - prevention & control | Alkaloids - adverse effects | Benzazepines - adverse effects | Smoking - drug therapy | Heterocyclic Compounds, 4 or More Rings - adverse effects | Nicotinic Agonists - therapeutic use | Nicotine - antagonists & inhibitors | Smoking Cessation - methods | Azepines - therapeutic use | Nicotine - adverse effects | Nicotinic Agonists - adverse effects | Heterocyclic Compounds, 4 or More Rings - therapeutic use | Benzazepines - therapeutic use | Counseling - methods | Alkaloids - therapeutic use | Quinolizines - adverse effects | Varenicline - therapeutic use | Bupropion - therapeutic use
Journal Article
Cochrane database of systematic reviews (Online), ISSN 1469-493X, 2012, Volume 4, Issue 4, p. CD006103
Journal Article
Journal Article
Journal Article
The American Journal of Chinese Medicine, ISSN 0192-415X, 2014, Volume 42, Issue 3, pp. 543 - 559
To discover and develop novel natural compounds, active ingredients, single herbs and combination formulas or prescriptions in traditional Chinese medicine... 
Combination Formula | Review | Natural Compound | Antitumor | Herb | Traditional Chinese Medicine | FORBESII BOISS EXTRACT | SOPHORA-FLAVESCENS | PANCREATIC-CANCER | CELL-CYCLE PROGRESSION | GANODERMA-LUCIDUM | ANTITUMOR-ACTIVITY | BREAST-CANCER CELLS | MEDICINE, GENERAL & INTERNAL | IN-VITRO | HEPATOCELLULAR-CARCINOMA | INTEGRATIVE & COMPLEMENTARY MEDICINE | NF-KAPPA-B | Quinolizines - therapeutic use | Antineoplastic Agents, Phytogenic | Podophyllotoxin - pharmacology | Quinolizines - isolation & purification | Humans | Molecular Conformation | Alkaloids - isolation & purification | Podophyllotoxin - therapeutic use | Drugs, Chinese Herbal - pharmacology | Molecular Targeted Therapy | Phenanthrenes - isolation & purification | Flavonoids - therapeutic use | Epoxy Compounds - pharmacology | Neoplasms - genetics | Flavonoids - pharmacology | Drugs, Chinese Herbal - therapeutic use | Epoxy Compounds - isolation & purification | Podophyllotoxin - isolation & purification | Diterpenes - pharmacology | Epoxy Compounds - therapeutic use | Amphibian Venoms - chemistry | Diterpenes - therapeutic use | Phenanthrenes - therapeutic use | Plants, Medicinal - chemistry | Alkaloids - pharmacology | Medicine, Chinese Traditional | Diterpenes - isolation & purification | Quinolizines - pharmacology | Amphibian Venoms - pharmacology | Berberine - isolation & purification | Drug Discovery | Neoplasms - drug therapy | Amphibian Venoms - therapeutic use | Berberine - pharmacology | Phenanthrenes - pharmacology | Animals | Drugs, Chinese Herbal - chemistry | Alkaloids - therapeutic use | Flavonoids - isolation & purification | Berberine - therapeutic use | Neoplasms - pathology | Amphibian Venoms - isolation & purification | Drug Combinations | Podophyllotoxin - analogs & derivatives | Antimitotic agents | Medicine, Chinese | Product development | Research | Antineoplastic agents | Health aspects
Journal Article